Our observation is consistent with evidence from Griffin et al. [25], which demonstrated increased Akt activation coinciding with elevated levels of inactive Ser9-phosphorylated GSK-3β in the temporal cortex of AD cases. Here, AKT1 is linked to Alzheimer disease.